Recombinant Human Erythropoietin Increases Blood Pressure, Platelet Aggregability and Platelet Free Calcium Mobilisation in Uraemic Children: A Possible Link?^[*]

 

PDF Download Buy Article Permissions and Reprints

Summary

Recombinant human erythropoietin was administered to 10 uraemic children on chronic haemodialysis, all of whom responded by correcting their haemoglobin. In addition, they showed an increase in blood pressure; platelet aggregations, subnormal before therapy, improved during treatment. The intracellular free calcium concentration in platelets after thrombin stimulation also increased significantly during erythropoietin administration. We hypothesize that the effect of erythropoietin on platelet aggregability and on blood pressure may be due to an increase in the intracellular free calcium mobilisation in platelets and possibly in smooth muscle cells respectively.

This paper is dedicated to Prof. Marc Verstraete on the occasion of his 65th birthday.

• References

• 1 Raine AE G. Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: implications of erythropoietin therapy. Lancet 1988; 1: 97-100
  PubMedGoogle Scholar
• 2 Tomson CR V, Venning MC, Ward MK. Blood pressure and erythropoietin. Lancet 1988; 1: 351
  PubMedGoogle Scholar
• 3 Martin J, Moncada S. Blood pressure, erythropoietin, and nitric oxide. Lancet 1988; 1: 644
  PubMedGoogle Scholar
• 4 Van Geet C, Hauglustaine D, Verresen L, Vanrusselt M, Vermylen J. Haemostatic effects of recombinant human erythropoietin in chronic haemodialysis patients. Thromb Haemostas 1989; 61: 117-121
  PubMedGoogle Scholar
• 5 Erne P, Bolli P, Burgener E, Buhler FR. Correlation of platelet calcium with blood pressure. N Engl J Med 1984; 310: 1084-1088
  CrossrefPubMedGoogle Scholar
• 6 André JL, Deschamps JP, Gueguen R, Jacques J. Tension artérielle chez I’enfant et’adolescent. Influence des modalités de mesure. Distribution des valeurs frégnentes et référence á I’age et á la taille. Arch Mai Coeur 1981; 74: 3-13
  PubMedGoogle Scholar
• 7 Ingram GI C, Hills M. The prothrombin time test. Effect of varying citrate concentration. Thromb Haemostas 1976; 36: 230-236
  PubMedGoogle Scholar
• 8 Rink TJ, Smith SW, Tsien RY. Cytoplasmic free Ca2+ in human platelets: Ca2+ thresholds and Ca2+-independent activation for shape-change and secretion. FEBS Lett 1982; 148: 21
  CrossrefPubMedGoogle Scholar
• 9 Ware JA, Clark BA, Smith M, Salzman EW. Abnormalities of cytoplasmic Ca2+ in platelets from patients with uremia. Blood 1989; 73: 172-176
  CrossrefPubMedGoogle Scholar
• 10 Burstein SA, Ishibashi T. Erythropoietin and megakaryocytopoiesis. Blood Cells 1989; 15: 193-201
  PubMedGoogle Scholar
• 11 Dessypris EN, Gleaton JH, Armstrong OL. Effect of human recombinant erythropoietin on human marrow megakaryocyte colony formation in vitro. Am J Haematol 1987; 65: 265-269
  CrossrefPubMedGoogle Scholar
• 12 Hoffman R, Straneva J, Young HH, Bruno E, Brandt J. New insights into the regulation of human megakaryocytopoiesis. Blood Cells 1987; 13: 75-86
  PubMedGoogle Scholar
• 13 Fraser JK, Tan AS, Lin FK, Berridge MV. Expression of specific high-affinity binding sites for erythropoietin on rat, and mouse megakaryocytes. Exp Hematol 1989; 17: 10-16
  PubMedGoogle Scholar
• 14 Fraser JK, Lin FK, Berridge MV. Expression of high affinity receptors for erythropoietin on human bone marrow cells and on the human erythroleukemic cell line, HEL. Exp Hematol 1988; 16: 836-842
  PubMedGoogle Scholar